NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that its board of directors has authorized the repurchase of $2 billion worth of shares of the firm's common stock, either in the open market or in negotiated transactions. The new authorization has no expiration date.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.